Dimensional Fund Advisors LP Synlogic, Inc. Transaction History

Dimensional Fund Advisors LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.42 - $0.68 $149,651 - $242,293	-356,314 Reduced 82.23%	77,009 $33,000
Q1 2023 May 12, 2023	SELL	$0.56 - $1.07 $21,196 - $40,499	-37,850 Reduced 8.03%	433,323 $272,000
Q3 2022 Nov 10, 2022	SELL	$0.91 - $14.63 $93,305 - $1.5 Million	-102,534 Reduced 17.87%	471,173 $448,000
Q2 2022 Aug 12, 2022	SELL	$0.89 - $2.47 $18,503 - $51,351	-20,790 Reduced 3.5%	573,707 $660,000
Q1 2022 May 13, 2022	SELL	$1.63 - $2.55 $61,403 - $96,061	-37,671 Reduced 5.96%	594,497 $1.43 Million
Q4 2021 Feb 09, 2022	SELL	$2.27 - $3.0 $185,506 - $245,163	-81,721 Reduced 11.45%	632,168 $1.53 Million
Q3 2021 Nov 12, 2021	SELL	$2.45 - $4.1 $585,417 - $979,678	-238,946 Reduced 25.08%	713,889 $2.18 Million
Q2 2021 Aug 12, 2021	SELL	$3.0 - $4.39 $56,100 - $82,093	-18,700 Reduced 1.92%	952,835 $3.71 Million
Q1 2021 May 14, 2021	SELL	$2.2 - $5.05 $21,773 - $49,979	-9,897 Reduced 1.01%	971,535 $3.48 Million
Q4 2020 Feb 25, 2021	BUY	$1.85 - $2.54 $1.82 Million - $2.49 Million	981,432 New	981,432 $2.12 Million

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.